Suppr超能文献

阿苯达唑治疗与美国入境难民的肠道寄生虫。

Albendazole therapy and enteric parasites in United States-bound refugees.

机构信息

Epidemic Intelligence Service, Atlanta, USA.

出版信息

N Engl J Med. 2012 Apr 19;366(16):1498-507. doi: 10.1056/NEJMoa1103360.

Abstract

BACKGROUND

Beginning on May 1, 1999, the Centers for Disease Control and Prevention (CDC) recommended presumptive treatment of refugees for intestinal parasites with a single dose of albendazole (600 mg), administered overseas before departure for the United States.

METHODS

We conducted a retrospective cohort study involving 26,956 African and Southeast Asian refugees who were screened by means of microscopical examination of stool specimens for intestinal parasites on resettlement in Minnesota between 1993 and 2007. Adjusted prevalence ratios for intestinal nematodes, schistosoma species, giardia, and entamoeba were calculated among refugees who migrated before versus those who migrated after the CDC recommendation of presumptive predeparture albendazole treatment.

RESULTS

Among 4370 untreated refugees, 20.8% had at least one stool nematode, most commonly hookworm (in 9.2%). Among 22,586 albendazole-treated refugees, only 4.7% had one or more nematodes, most commonly trichuris (in 3.9%). After adjustment for sex, age, and region, albendazole-treated refugees were less likely than untreated refugees to have any nematodes (prevalence ratio, 0.19), ascaris (prevalence ratio, 0.06), hookworm (prevalence ratio, 0.07), or trichuris (prevalence ratio, 0.27) but were not less likely to have giardia or entamoeba. Schistosoma ova were identified exclusively among African refugees and were less prevalent among those treated with albendazole (prevalence ratio, 0.60). After implementation of the albendazole protocol, the most common pathogens among 17,011 African refugees were giardia (in 5.7%), trichuris (in 5.0%), and schistosoma (in 1.8%); among 5575 Southeast Asian refugees, only giardia remained highly prevalent (present in 17.2%). No serious adverse events associated with albendazole use were reported.

CONCLUSIONS

Presumptive albendazole therapy administered overseas before departure for the United States was associated with a decrease in the prevalence of intestinal nematodes among newly arrived African and Southeast Asian refugees.

摘要

背景

自 1999 年 5 月 1 日起,疾病控制与预防中心(CDC)建议对难民进行疑似肠道寄生虫治疗,方法是在前往美国之前,给予一剂阿苯达唑(600mg)。

方法

我们进行了一项回顾性队列研究,共涉及 26956 名非洲和东南亚难民,他们于 1993 年至 2007 年在明尼苏达州重新安置期间通过粪便显微镜检查进行肠道寄生虫筛查。在 CDC 建议进行疑似出发前阿苯达唑治疗之前和之后,计算出移民的难民中肠道线虫、血吸虫、贾第虫和内阿米巴的调整后流行率比。

结果

在 4370 名未接受治疗的难民中,20.8%至少有一种肠道线虫,最常见的是钩虫(9.2%)。在 22586 名接受阿苯达唑治疗的难民中,只有 4.7%有一种或多种线虫,最常见的是鞭虫(3.9%)。调整性别、年龄和地区后,接受阿苯达唑治疗的难民患任何线虫(流行率比,0.19)、蛔虫(流行率比,0.06)、钩虫(流行率比,0.07)或鞭虫(流行率比,0.27)的可能性低于未接受治疗的难民,但患贾第虫或内阿米巴的可能性则无差异。血吸虫卵仅在非洲难民中发现,且在接受阿苯达唑治疗的患者中更为少见(流行率比,0.60)。阿苯达唑方案实施后,17011 名非洲难民中最常见的病原体是贾第虫(5.7%)、鞭虫(5.0%)和血吸虫(1.8%);在 5575 名东南亚难民中,只有贾第虫仍然高度流行(17.2%)。未报告与使用阿苯达唑相关的严重不良事件。

结论

在前往美国之前,在海外给予疑似阿苯达唑治疗与新抵达的非洲和东南亚难民中肠道线虫的流行率降低有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验